Hugel, Inc. (KOSDAQ:145020)
359,000
-1,000 (-0.28%)
Aug 8, 2025, 3:30 PM KST
Hugel Market Cap
Hugel has a market cap or net worth of 3.66 trillion as of August 8, 2025. Its market cap has increased by 46.54% in one year.
Market Cap
3.66T
Enterprise Value
3.27T
Revenue
388.56B
Ranking
n/a
PE Ratio
28.08
Stock Price
359,000.00
Market Cap Chart
Since December 24, 2015, Hugel's market cap has increased from 552.70B to 3.66T, an increase of 561.86%. That is a compound annual growth rate of 21.69%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 7, 2025 | 3,658.10B | 18.42% |
Dec 30, 2024 | 3,089.09B | 84.38% |
Dec 28, 2023 | 1,675.39B | 4.84% |
Dec 29, 2022 | 1,597.99B | -14.29% |
Dec 30, 2021 | 1,864.45B | -20.74% |
Dec 30, 2020 | 2,352.30B | 75.24% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Dec 24, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Biologics | 73.38T |
Celltrion | 39.35T |
ALTEOGEN | 23.49T |
Yuhan | 8,568.09B |
SK Biopharmaceuticals | 7,948.79B |
Peptron | 7,292.07B |
PharmaResearch | 6,213.01B |
HLB Co., Ltd. | 6,099.84B |